Authors: Schuller, J Cassidy, J Dumont, E Roos, B Durston, S Banken, L Utoh, M Mori, K Weidekamm, E Reigner, B

Citation: J. Schuller et al., Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients, CANC CHEMOT, 45(4), 2000, pp. 291-297

Authors: Twelves, C Glynne-Jones, R Cassidy, J Schuller, J Goggin, T Roos, B Banken, L Utoh, M Weidekamm, E Reigner, B

Citation: C. Twelves et al., Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites, CLIN CANC R, 5(7), 1999, pp. 1696-1702

Authors: Reigner, B Clive, S Cassidy, J Jodrell, D Schulz, R Goggin, T Banken, L Roos, B Utoh, M Mulligan, T Weidekamm, E

Citation: B. Reigner et al., Influence of the antacid Maalox on the pharmacokinetics of capecitabine incancer patients, CANC CHEMOT, 43(4), 1999, pp. 309-315